Quick Answer
ATOSSA THERAPEUTICS, INC. reported Stockholders Equity of $39.35 million for the year ending 2025.
- ATOSSA THERAPEUTICS, INC. showed a decrease of -44.9% in Stockholders Equity from 2024 to 2025.
- This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $10.60 million | Q1 2014: $21.30 million | Q2 2014: $18.26 million | Q3 2014: $15.23 million | Q1 2015: $10.28 million | Q2 2015: $13.12 million | Q3 2015: $9.06 million | Q1 2016: $3.77 million | Q2 2016: $2.41 million | Q3 2016: $5.41 million | Q1 2017: $1.53 million | Q2 2017: $2.80 million | Q3 2017: $2.56 million | Q1 2018: $5.26 million | Q2 2018: $13.57 million | Q3 2018: $10.57 million | Q1 2019: $19.50 million | Q2 2019: $17.55 million | Q3 2019: $15.02 million | Q1 2020: $10.90 million | Q2 2020: $8.37 million | Q3 2020: $9.87 million | Q1 2021: $139.70 million | Q2 2021: $144.07 million | Q3 2021: $141.35 million | Q1 2022: $135.16 million | Q2 2022: $130.26 million | Q3 2022: $123.86 million | Q1 2023: $113.26 million | Q2 2023: $104.88 million | Q3 2023: $98.25 million | Q1 2024: $85.76 million | Q2 2024: $80.16 million | Q3 2024: $73.68 million | Q1 2025: $65.32 million | Q2 2025: $57.70 million | Q3 2025: $49.79 million.
- Over the full 18 years of available data (2009 to 2025), ATOSSA THERAPEUTICS, INC.'s Stockholders Equity has grown by 72,775.9%.
- Historical annual values: Fiscal year 2025: $39.35 million | Fiscal year 2024: $71.48 million | Fiscal year 2023: $91.02 million | Fiscal year 2022: $117.96 million | Fiscal year 2021: $138.14 million | Fiscal year 2020: $27.17 million | Fiscal year 2019: $13.16 million | Fiscal year 2018: $8.81 million | Fiscal year 2017: $6.94 million | Fiscal year 2016: $3.10 million | Fiscal year 2015: $3.74 million | Fiscal year 2014: $9.50 million | Fiscal year 2013: $10.60 million | Fiscal year 2012: $5.18 million | Fiscal year 2011: $1.56 million | Fiscal year 2010: -$851.9 thousand | Fiscal year 2009: $31.7 thousand | Fiscal year 2009: $54.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: